Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates, as ...

Takeda (TOKYO:4502/NYSE:TAK) announced today that its Board of Directors made the decision unanimously to appoint Julie Kim, ...

Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended December 31, 2024) showing continued advancement of its Growth & Launch ...

NET PROFIT FORECAST: Takeda is expected to post a 59% drop in net profit to 43.58 billion yen, equivalent to $280.2 million, for the three months ended Dec. 31, according to a poll of analysts by data ...

Takeda Canada Inc., the Canadian organization of Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that non-profit ...

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®– (normal immunoglobulin [human] 10% and ...

Akkodis, a global digital engineering company and Smart Industry leader, is proud to announce the acquisition of Barhead ...

Fintel reports that on January 29, 2025, Oppenheimer upgraded their outlook for Ovid Therapeutics (NasdaqGS:OVID) from ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Weekly magazine Shukan Bunshun corrected a key part of its initial scoop on the “trouble” between celebrity Masahiro Nakai ...

Innovative structural color coatings from Chiba University combine hydrophobic melanin particles, offering long-lasting ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...